WEKO3
アイテム
Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas
https://repo.qst.go.jp/records/63849
https://repo.qst.go.jp/records/638495db21b48-e536-4ea9-a3e9-60079984c40a
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-03-24 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kamada, Tadashi
× Kamada, Tadashi× Imai, Reiko× Tsuji, Hiroshi× Suzuki, Motohisa× Okada, Tohru× Sugahara, Shinji× Tsujii, Hirohiko× 鎌田 正× 今井 礼子× 辻 比呂志× 鈴木 志恒× 岡田 徹× 菅原 信二× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2009, a total of 471 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | II NIRS-CNAO Joint Symposium on Hadrontherapy | |||||
発表年月日 | ||||||
日付 | 2010-03-21 | |||||
日付タイプ | Issued |